首页|期刊导航|中华医学杂志（英文版）|A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019

Fengqin Zhang Yanqiu Wei Li He Huilan Zhang Qiongjie Hu Huihui Yue Jianhan He Huaping Dai

中华医学杂志（英文版）2022，Vol.135Issue(3)：368-370,3.

中华医学杂志（英文版）2022，Vol.135Issue(3)：368-370,3.DOI:10.1097/CM9.0000000000001614

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019

Fengqin Zhang ¹Yanqiu Wei ²Li He ³Huilan Zhang ⁴Qiongjie Hu ¹Huihui Yue ⁵Jianhan He ¹Huaping Dai¹

作者信息

1. Department of Respiratory and Critical Care Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China
2. Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 10029,China
3. Peking University Health Science Center,Beijing 100029,China
4. Department of Respiratory and Critical Care Medicine,Jingzhou Central Hospital,Jingzhou,Hubei 434200,China
5. Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China
折叠

摘要

引用本文复制引用

Fengqin Zhang,Yanqiu Wei,Li He,Huilan Zhang,Qiongjie Hu,Huihui Yue,Jianhan He,Huaping Dai..A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019[J].中华医学杂志（英文版）,2022,135(3):368-370,3.

基金项目

This study was supported by grants from the SARS-CoV-2 Pneumonia Emergency Technology Public Relation Project of Tongji Medical College,Huazhong University of Science and Technology (No.2020kfyXGYJ043),the National Natural Science Foundation of China (No.81974456) （No.2020kfyXGYJ043）

and the SARS-CoV-2 Pneumonia Emergency Technology Public Relation Project (No.2020FCA009). （No.2020FCA009）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航